Canon and AVEVA form imaging technologies joint venture for smart factories
The Japan-based t...
Canon has confirmed its partnership with AVEVA Group with the focus of realising smart factories through Canon imaging technologies.
The Japan-based technology company will aim to create innovative facilities in which it will utilise production equipment and machinery connected to a network.
The project aims to increase the awareness and drive towards the automation of factories whilst improving productivity.
Hiroo Edakubo, Deputy Chief Executive of Image Solutions Business Operations of Canon, commented: “Canon’s partnership with AVEVA is an exciting opportunity for the company to realise the full potential of smart factories by automating routine, repetitive, and labour-intensive tasks, through the Canon Industrial Imaging Platform.”
“Implementing features such as video recording and image processing technologies will, ultimately, result in faster recovery, problem prevention, and streamlined operations across the factory floor.”
“It will also help free up workers and allow them to use their time more productively and focus on tasks best suited to their skills and abilities.”
- Airbus and Boeing to combine $3.1bn order of 19 jets from Vistara
- BASF completes $10bn chemical complex deal in China
- Alibaba to invest in Smartrac to increase brand protection
- Read the latest issue of Manufacturing Global here
Canon’s products – such as network cameras, industrial cameras and software for production centres – will be integrated through AVEVA’s InTouch SCADA1 programme powered by Wonderware.
Canon has also confirmed that it will utilise AVEVA’s software with Canon network cameras from the start of September.
With the software, Canon aims to enable remote monitoring of factory floors from its production control departments and central monitoring rooms.
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.